These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2543433)

  • 1. Antibody recognition of SIVmac envelope peptides in plasma from macaques experimentally infected with SIV/Mne.
    Shafferman A; Layne A; Sadoff J; Burke DS; Morton WR; Benveniste RE
    AIDS Res Hum Retroviruses; 1989 Jun; 5(3):327-36. PubMed ID: 2543433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.
    Silvera P; Flanagan B; Kent K; Rud E; Powell C; Corcoran T; Bruck C; Thiriart C; Haigwood NL; Stott EJ
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1295-304. PubMed ID: 7848685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization and comparison of simian immunodeficiency virus isolates from macaques, mangabeys, and African green monkeys.
    Benveniste RE; Raben D; Hill RW; Knott WB; Drummond JE; Arthur LO; Jahrling PB; Morton WR; Henderson LE; Heidecker G
    J Med Primatol; 1989; 18(3-4):287-303. PubMed ID: 2547964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection.
    Shafferman A; Lennox J; Grosfeld H; Sadoff J; Redfield RR; Burke DS
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):33-9. PubMed ID: 2541748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.
    Matsumi S; Matsushita S; Yoshimura K; Javaherian K; Takatsuki K
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):501-8. PubMed ID: 7632464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein.
    Jurkiewicz E; Hunsmann G; Schäffner J; Nisslein T; Lüke W; Petry H
    J Virol; 1997 Dec; 71(12):9475-81. PubMed ID: 9371609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of B-cell epitopes in the envelope glycoproteins of simian immunodeficiency virus.
    Benichou S; Venet A; Beyer C; Tiollais P; Madaule P
    Virology; 1993 Jun; 194(2):870-4. PubMed ID: 7684879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac) induced by infection and vaccination.
    McBride BW; Corthals G; Rud E; Kent K; Webster S; Cook N; Cranage MP
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1033-41. PubMed ID: 7685372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
    Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection.
    Lewis MG; Elkins WR; McCutchan FE; Benveniste RE; Lai CY; Montefiori DC; Burke DS; Eddy GA; Shafferman A
    Vaccine; 1993 Oct; 11(13):1347-55. PubMed ID: 7507625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia.
    Zhang JY; Martin LN; Watson EA; Montelaro RC; West M; Epstein L; Murphey-Corb M
    J Infect Dis; 1988 Dec; 158(6):1277-86. PubMed ID: 2848903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses.
    Simon F; Souquière S; Damond F; Kfutwah A; Makuwa M; Leroy E; Rouquet P; Berthier JL; Rigoulet J; Lecu A; Telfer PT; Pandrea I; Plantier JC; Barré-Sinoussi F; Roques P; Müller-Trutwin MC; Apetrei C
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):937-52. PubMed ID: 11461679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.
    Naidu YM; Kestler HW; Li Y; Butler CV; Silva DP; Schmidt DK; Troup CD; Sehgal PK; Sonigo P; Daniel MD
    J Virol; 1988 Dec; 62(12):4691-6. PubMed ID: 2846880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monoclonal antibodies that distinguish simian immunodeficiency virus isolates from each other and from human immunodeficiency virus types 1 and 2.
    Sutjipto S; Kodama T; Yee J; Gettie A; Jennings M; Desrosiers RC; Marx PA
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():247-9. PubMed ID: 1689369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.
    Glamann J; Burton DR; Parren PW; Ditzel HJ; Kent KA; Arnold C; Montefiori D; Hirsch VM
    J Virol; 1998 Jan; 72(1):585-92. PubMed ID: 9420262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1.
    Javaherian K; Langlois AJ; Schmidt S; Kaufmann M; Cates N; Langedijk JP; Meloen RH; Desrosiers RC; Burns DP; Bolognesi DP
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1418-22. PubMed ID: 1371358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies.
    Chackerian B; Rudensey LM; Overbaugh J
    J Virol; 1997 Oct; 71(10):7719-27. PubMed ID: 9311856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simian immunodeficiency virus from African green monkeys.
    Daniel MD; Li Y; Naidu YM; Durda PJ; Schmidt DK; Troup CD; Silva DP; MacKey JJ; Kestler HW; Sehgal PK
    J Virol; 1988 Nov; 62(11):4123-8. PubMed ID: 3172340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.